UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 8

of 'Molecularly targeted therapy for metastatic melanoma'

8
TI
Vemurafenib in patients with BRAF V600 mutation-positive metastatic melanoma: final overall survival results of the randomised BRIM-3 study
AU
Chapman PB, Robert C, Larkin J, et al
SO
Ann Oncol. 2017;
 
AD